moxalactam has been researched along with Kidney Failure, Chronic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (92.86) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fillastre, JP; Humbert, G; Leroy, A | 2 |
| Aronoff, GR; Kleit, SA; Luft, FC; Mong, SA; Sloan, RS | 1 |
| Malow, JB; Panwalker, AP; Porembski, PE; Ramirez, CA; Trager, GM; Zar, FA | 1 |
| Jacobson, EJ; Nissenson, AR; Zahrowski, JJ | 1 |
| Bean, B; Fasching, CE; Gerding, DN; Korchik, WP; Peterson, LR | 1 |
| Neu, HC; Srinivasan, S | 1 |
| Wills, PJ; Wise, R; Wright, N | 1 |
| Berry, PL; Kaplan, SL; Kramer, WG; Mason, EO | 1 |
| Clark, J; D'Elia, JA; Hochman, R; Kaldany, A; Miller, DG; Rolla, AR; Thomas, S | 1 |
| Kumano, K; Kuroyama, M; Mashimo, S; Sakai, T; Tomonaga, F | 1 |
| Apicella, MA; Morse, GD; Walshe, JJ | 1 |
| Imai, T; Inoue, T; Kajimoto, Y; Sakaguchi, K; Shirai, D; Yoshida, K | 1 |
| Apicella, M; Cafarell, R; Janicke, D; Jusko, WJ; Morse, G; Piontek, K; Walshe, J | 1 |
14 other study(ies) available for moxalactam and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Pharmacokinetics of moxalactam in adults].
Topics: Adult; Cephalosporins; Cephamycins; Diffusion; Half-Life; Humans; Kidney; Kidney Failure, Chronic; Kinetics; Moxalactam; Renal Dialysis; Tissue Distribution | 1983 |
Moxalactam pharmacokinetics during hemodialysis.
Topics: Aged; Cephalosporins; Cephamycins; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Middle Aged; Moxalactam; Renal Dialysis | 1981 |
Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Osteomyelitis; Pseudomonas aeruginosa; Serratia marcescens; Skin Diseases, Infectious; Urinary Tract Infections | 1981 |
Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Metabolic Clearance Rate; Middle Aged; Moxalactam | 1981 |
Moxalactam kinetics in hemodialysis.
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Moxalactam; Renal Dialysis | 1981 |
Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.
Topics: Blood Proteins; Cephalosporins; Cephamycins; Humans; Kidney Failure, Chronic; Kinetics; Moxalactam; Protein Binding; Renal Dialysis; Time Factors; Tissue Distribution | 1981 |
Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
Topics: Adult; Aged; Cephalosporins; Cephamycins; Enterobacteriaceae; Female; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Moxalactam; Renal Dialysis | 1981 |
The pharmacokinetics of moxalactam in renal failure.
Topics: Cephalosporins; Cephamycins; Escherichia coli; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Microbial Sensitivity Tests; Moxalactam; Renal Dialysis; Stereoisomerism | 1981 |
Pharmacokinetics of moxalactam in anuric children and during hemodialysis.
Topics: Adolescent; Adult; Anuria; Child; Child, Preschool; Half-Life; Humans; Kidney; Kidney Failure, Chronic; Kinetics; Moxalactam; Regression Analysis; Renal Dialysis | 1983 |
Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Blood Coagulation Disorders; Cephalosporins; Female; Humans; Hypoprothrombinemias; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Prothrombin Time; Renal Dialysis | 1983 |
[Protein binding of various cephems in healthy subjects and patients with chronic renal failure].
Topics: Adult; Cephalosporins; Cephalothin; Fatty Acids, Nonesterified; Female; Humans; Kidney Failure, Chronic; Lipase; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Protein Binding; Renal Dialysis; Serum Albumin | 1991 |
Absorption of intraperitoneal antibiotics.
Topics: Absorption; Anti-Bacterial Agents; Cefamandole; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Moxalactam; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Radioimmunoassay; Tobramycin; Vancomycin | 1988 |
[Effect of latamoxef on platelet aggregation in hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients].
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Peritoneal Dialysis, Continuous Ambulatory; Platelet Aggregation; Renal Dialysis | 1986 |
Moxalactam epimer disposition in patients undergoing continuous ambulatory peritoneal dialysis.
Topics: Adult; Biological Availability; Diarrhea; Female; Humans; Infusions, Parenteral; Injections, Intraperitoneal; Injections, Intravenous; Kidney Failure, Chronic; Kinetics; Male; Moxalactam; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Stereoisomerism | 1985 |